新生血管性年龄相关性黄斑变性患者法瑞西单抗治疗后黄斑新生血管架构的形态学变化:初治眼与转换眼比较
前瞻性研究分析45只新生血管性年龄相关性黄斑变性眼(初治18只、转换27只)接受法瑞西单抗治疗,用光学相干断层扫描血管成像量化黄斑新生血管架构变化,随访至1年。治疗后黄斑新生血管面积、血管面积、分叉数和总血管长度下降,空隙度增加,初治眼变化更明显但转换眼终点数仅转换眼下降,1年时转换眼多项指标仍较大。
要点
- 法瑞西单抗可诱导黄斑新生血管网络显著且持续重塑,初治眼变化更明显。
- 治疗后黄斑新生血管面积、血管面积、分叉数和总血管长度下降,空隙度增加。
- 变化主要由负荷期驱动,随后至1年随访保持稳定。
核心结论
- 法瑞西单抗诱导新生血管性年龄相关性黄斑变性黄斑新生血管网络显著且持续重塑,初治眼变化更明显。
- 这些变化主要由负荷期驱动,随后至1年随访保持稳定。
研究设计与样本
- 前瞻性研究分析45只新生血管性年龄相关性黄斑变性眼,其中初治18只、转换27只,接受法瑞西单抗治疗。
- 使用AngioTool v0.6a量化黄斑新生血管面积、血管面积、血管密度、分叉数、分支指数、总血管长度、终点数和空隙度。
- 随访时间点为基线(V0)、负荷期结束(V1)和1年(V2)。
主要发现
- 基线时转换眼黄斑新生血管面积(P < 0.001)、血管面积(P < 0.001)、分叉数(P = 0.004)、血管长度(P < 0.001)、平均血管长度(P = 0.02)、终点数(P = 0.002)和空隙度(P = 0.04)均大于初治眼。
- 基线时初治眼血管密度(P < 0.001)和分支指数(P = 0.007)高于转换眼。
- 治疗后黄斑新生血管面积(P < 0.001)、血管面积(P < 0.001)、分叉数(P = 0.001)和总血管长度(P < 0.001)下降,空隙度增加(P = 0.001)。
- 初治眼变化更大,但终点数仅在转换眼下降(P = 0.01),初治眼保持稳定。
- V2时转换眼黄斑新生血管面积(P = 0.007)、血管面积(P = 0.004)、分叉数(P = 0.002)、血管长度(P = 0.004)和终点数(P = 0.007)仍较大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the morphometric changes in macular neovascularization (MNV) architecture after faricimab treatment in neovascular age-related macular degeneration, comparing treatment-naive and previously treated eyes. METHODS: Prospective study analyzing 45 eyes (18 treatment naive, 27 switched) with neovascular age-related macular degeneration undergoing faricimab treatment. Optical coherence tomography angiography images were exported and the quantification of changes in MNV area, vessel area, vessel density, number of junctions, branching index, total vessel length, end points, and lacunarity was performed using AngioTool v0.6a. Follow-ups at baseline (V0), at the end of the loading phase (V1), and at 1 year (V2) were collected. RESULTS: Baseline MNV characteristics differed significantly between treatment-naive and switched eyes. Switched eyes exhibited greater MNV area ( P < 0.001), vessel area ( P < 0.001), junction count ( P = 0.004), vessel length ( P < 0.001), average vessel length ( P = 0.02), end point count ( P = 0.002), and lacunarity ( P = 0.04). Conversely, naive eyes had higher vessel density ( P < 0.001) and branching index ( P = 0.007). Posttreatment, MNV area ( P < 0.001), vessel area ( P < 0.001), junction count ( P = 0.001), and total vessel length ( P < 0.001) decreased, whereas lacunarity increased ( P = 0.001). Greater changes were observed in naive eyes, but the end point count only reduced in switched eyes ( P = 0.01), being stable in naive eyes. At V2, switched eyes still had larger MNV area ( P = 0.007), vessel area ( P = 0.004), junction count ( P = 0.002), vessel length ( P = 0.004), and end points ( P = 0.007). CONCLUSION: Faricimab induces significant and sustained remodeling of the MNV network in neovascular age-related macular degeneration, with more pronounced changes in treatment-naive eyes. These changes were primarily driven by the loading phase, but then remained stable toward the 1-year follow-up.
引用
- Carlà MM, Scampoli A, Grieco G, et al. MORPHOMETRIC CHANGES IN MACULAR NEOVASCULARIZATION ARCHITECTURE AFTER FARICIMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Comparison Between Naive and Switched Eyes. Retina. 2026. PMID: 40802977. doi:10.1097/IAE.0000000000004635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。